Welcome to our dedicated page for Emera news (Ticker: EMA), a resource for investors and traders seeking the latest updates and insights on Emera stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Emera's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Emera's position in the market.
Emera Inc. (TSX/NYSE: EMA) has announced its quarterly dividend declarations for both common and preferred shares. The company's Board of Directors has declared a dividend of $0.7250 per common share and various dividends for different series of First Preferred Shares, ranging from $0.1364 to $0.40213 per share.
All dividends will be payable on August 15, 2025, to shareholders of record as of August 1, 2025. The company has confirmed that these dividends qualify as eligible dividends under the Income Tax Act (Canada) and corresponding provincial legislation.
Emera (TSX: EMA) has scheduled its Q2 2025 earnings release for Friday, August 8, 2025, before markets open. The company will host a teleconference and webcast at 9:30 a.m. Atlantic (8:30 a.m. Eastern) on the same day to discuss the results.
Participants can join the call by dialing 1-800-717-1738 (North America) or 1-289-514-5100 (International). A live and archived audio webcast will be available on Emera's website, with a replay accessible two hours after the call concludes.
Emera (TSX/NYSE: EMA) has announced important details regarding the conversion privileges of its preferred shares. The company will not redeem its 4,866,814 Series A Shares or 1,133,186 Series B Shares on August 15, 2025. Instead, shareholders of both series will have the option to either retain their current shares or convert them on a one-for-one basis.
Series A shareholders can maintain their fixed-rate quarterly dividend or convert to Series B for a floating rate dividend. Series B shareholders can keep their floating rate dividend or convert to Series A for a fixed rate. The conversion period runs from July 16, 2025, to July 31, 2025 (5:00 PM EDT). New dividend rates for both series will be announced on July 16, 2025.
FAQ
What is the current stock price of Emera (EMA)?
What is the market cap of Emera (EMA)?
